Out-of-Hospital Treatment of Hepatitis C Increases Retention in Care among People Who Inject Drugs and Homeless Persons: An Observational Study

por Bianca Granozzi, Viola Guardigni, Lorenzo Badia, Elena Rosselli Del Turco, Alberto Zuppiroli, Beatrice Tazza, Pietro Malosso, Stefano Pieralli, Pierluigi Viale, Gabriella Verucchi
Publicado 2021

A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy

por Cesare Mazzaro, Luca Quartuccio, Luigi Elio Adinolfi, Dario Roccatello, Gabriele Pozzato, Riccardo Nevola, Maurizio Tonizzo, Stefano Gitto, Pietro Andreone, Valter Gattei
Publicado 2021

Daclatasvir–sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

por Pol S, Corouge M, Vallet-Pichard A
Publicado 2016

Effect of Successful Direct Acting Antivirals Therapy on Liver Stiffness in Patients with Chronic HCV Infection

por Ibrahim Anam Ezzelregal, Fathya Mostafa Elraie, Khalid Elmola, Mostafa Mohamed Shaqueer
Publicado 2020

Effect of different direct-acting antiviral regimens for treatment of nondiabetic hepatitis C virus–infected Egyptian patients on insulin resistance and sensitivity

por Tarek Yosef, Wesam Ahmed Ibrahim, Ahmed El-Ghandour, Soha Attia, Sarah El-Nakeep
Publicado 2021

Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy

por Stefania Farcomeni, Sonia Moretti, Caterina Fimiani, Lucia Fontanelli Sulekova, Fenicia Vescio, Leonardo Sernicola, Maria T. Maggiorella, Anna Lisa Remoli, Orietta Picconi, Luciana Mosca, Rozenn Esvan, Elisa Biliotti, Massimo Ciccozzi, Marco Sgarbanti, Gloria Taliani, Alessandra Borsetti
Publicado 2021

An Updated View on the Antiviral Therapy of Hepatitis C in Chronic Kidney Disease

por Fabrizio Fabrizi, Roberta Cerutti, Piergiorgio Messa
Publicado 2021

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection

por Bernstein D, Tripathi R, Cohen DE
Publicado 2019

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection

por Sundaram V, Kowdley KV
Publicado 2016

Possible acute rejection associated with the use of the new antihepatitis C virus medications

por Khaled Ar Karkout, Saleema Al Sherif, Qutaiba Hussein, Alia Albawardi, Yousef Boobes
Publicado 2019

Efficacy of Ombitasvir/Paritaprevir/Ritonavir plus Ribavirin in Treatment of Chronic Hepatitis C Patients with End Stage Renal Disease on Regular Hemodialysis

por Naglaa El-Gendy, Fathiya EL-Raey, Sherif Nassib, Noha Elsadany
Publicado 2020

Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan

por Chun-Ming Hong, You-Yu Lin, Chun-Jen Liu, Ya-Yun Lai, Shiou-Hwei Yeh, Hung-Chih Yang, Jia-Horng Kao, Shih-Jer Hsu, Yi-Hsiang Huang, Sheng-Shun Yang, Hsing-Tao Kuo, Pin-Nan Cheng, Ming-Lung Yu, Pei-Jer Chen
Publicado 2021

Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response

por Oana Irina Gavril, Lidia Iuliana Arhire, Otilia Gavrilescu, Mihaela Dranga, Oana Barboi, Radu Sebastian Gavril, Roxana Popescu, Cristina Cijevschi Prelipcean, Anca-Victorita Trifan, Catalina Mihai
Publicado 2021

Imaging of Virus-Infected Cells with Soft X-ray Tomography

por Damià Garriga, Francisco Javier Chichón, Bárbara M. Calisto, Diego S. Ferrero, Pablo Gastaminza, Eva Pereiro, Ana Joaquina Pérez-Berna
Publicado 2021